Mahai Chris LaVictoire
Director · abrdn Life Sciences Investors
Every open-market stock purchase Mahai Chris LaVictoire has reported to the SEC on Form 4 that met our signal bar, parsed straight from the filings. This page tracks where how the prices paid compare to where the stock trades now.
Where the buys stand today
- THWabrdn World Healthcare Fund
One purchase totalling $10.5K at an average of $13.20 per share. See all insider buying in THW →
Avg price paid$13.20Latest price—Market capUnknown - THQabrdn Healthcare Opportunities Fund
One purchase totalling $10.5K at an average of $18.49 per share. See all insider buying in THQ →
Avg price paid$18.49Latest price—Market capUnknown - HQHabrdn Healthcare Investors
One purchase totalling $10.5K at an average of $20.96 per share. See all insider buying in HQH →
Avg price paid$20.96Latest price—Market capUnknown - HQLabrdn Life Sciences Investors
One purchase totalling $10.5K at an average of $19.92 per share. See all insider buying in HQL →
Avg price paid$19.92Latest price—Market capUnknown
All reported buys
Follow new qualifying clusters involving Mahai Chris LaVictoire or other insiders
Explore qualifying clusters from public SEC filings. Pro adds email and Telegram notifications after detection.
About this data
Figures are parsed from Mahai Chris LaVictoire's Form 4 filings on SEC EDGAR (CIK 1335892) and cover open-market purchases (transaction code P) — grants, option exercises, and sales are excluded, which is why totals here can differ from raw filing counts. Every row links to its source document.
This page is informational and reflects public filing data. It is not investment advice.